Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,754 evidence items · page 54 / 71

820 batsBetween December 2018 and November 2019, samples were collected from 820 bats from an Eidolon helvum colony.

Camerounebolavirusesobserved December 2018 to November 2019published 2022VirusesOpenAlexdocument of 2 observationsDOI 10.3390/v14030560

3,045 adults3,045 adults had blood sugar tests.

Cameroundiabète (non précisé)published 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

-0.2 z-score_per_10.8_folate_unitsThere was an inverse association between serum folate and metabolic syndrome score of −0.20 in the z-score per 10.8 units of folate (95% CI: −0.38 to −0.02) after adjustment for socio-demographic factors, smoking status, alcohol intake, BMI, and physical activity.

Camerounsyndrome métaboliquepublished 2021Nutrientseurope_pmcdocument of 9 observationsDOI 10.3390/nu14010178

11 %Cardiovascular disease (CVD) is the second most common cause of death after infectious disease in most African countries, accounting for 11 percent of total deaths.

Camerounmaladies cardiovasculairesobserved 1999published 2006Cardiovascular Diseaseeurope_pmcdocument of 5 observations

5.9 IU/mLStroke patients had higher fasting insulin levels compared to controls (5.9 ± 5.4 vs 2.3 ± 3.2 IU/mL).

CamerounAVCpublished 2012Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Aeurope_pmcdocument of 4 observations

Hypertension was defined as systolic BP ≥140 mm Hg and/or diastolic ≥90 mm Hg in the MMM17 survey in Cameroon.

Camerounhypertension artérielleobserved 2017published 2021Health science reportseurope_pmcdocument of 5 observations

150 FFLe coût mensuel de la prise en charge thérapeutique par enfant malade de drépanocytose au Cameroun peut varier de 150 à 1000 FF selon que l’enfant est en crise ou non, en fonction de la gravité de la crise et de sa durée.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

12.7 %Une étude menée au Cameroun a trouvé que 12,7 % des participants avaient une pression artérielle élevée.

Camerounpression artérielle élevéeHAL · Unilimdocument of 857 observations

34 %Treatment rates for high blood pressure reached 34% in urban Cameroon.

Camerounhypertension artériellepublished 2001Journal of hypertensioneurope_pmcdocument of 7 observationsDOI 10.1097/00004872-200101000-00006

1.71 yearsThe median age at diagnosis of congenital adrenal hyperplasia was 1.71 years among Cameroonian patients.

Camerouncongenital adrenal hyperplasiapublished 2022Journal of pediatric endocrinology & metabolism : JPEMeurope_pmcdocument of 6 observations

88.5 %88.5% of participants were on antiretroviral treatment.

CamerounVIH/sidapublished 2017Tropical diseases, travel medicine and vaccineseurope_pmcdocument of 8 observations

50 %Cardiomyopathy may affect up to 50% of all diabetic patients.

Camerouncardiomyopathy · diabète (non précisé)published 2003Journal of cardiovascular riskeurope_pmcdocument of 10 observations

98 %T gondii seroprevalence was 98% (96 of 98) in Cameroon.

CamerounT gondiiHAL · Unilimdocument of 205 observations

15 %Close to 15% of patients with stroke have diabetes in sub-Saharan Africa.

CamerounAVC · diabète (non précisé)published 2005Circulationeurope_pmcdocument of 5 observationsDOI 10.1161/circulationaha.105.544312

5.9 yearsThe mean duration of diabetes was 5.9±5.1 years.

Cameroundiabète de type 1published 2022Annales de cardiologie et d'angeiologieeurope_pmcdocument of 8 observations

94.1 %Overall, sensitivities of the evaluated HIV diagnostic tests ranged between 94.1% and 100%.

CamerounVIH/sidapublished 2009PloS oneeurope_pmcdocument of 6 observations

The HLA DR3 appears to be the most predominant HLA haplotype amongst people with type 1 diabetes in sub-Saharan Africa than the HLA DR4 haplotype.

Cameroundiabète de type 1published 2023Frontiers in public healtheurope_pmcdocument of 3 observationsDOI 10.3389/fpubh.2023.1014626

0.5 %Insectivorous bats were infected with beta-coronaviruses from the Merbecovirus subgenus at a rate of 0.5%.

Camerounbeta-coronavirusespublished 2023VirusesOpenAlexdocument of 9 observationsDOI 10.3390/v15020337

79.8 %The most frequent type of crisis reported by the validation team were tonic-clonic crises (79.8%), SCEs exhibiting partial crises and with absence of crises were also reported in 10.4% and 9.8% of cases, respectively.

CamerounépilepsieHAL · Unilimdocument of 53 observations

100 %RH5 antigen expression was predicted in 100.0% of the subset of patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

8.34 %Au Cameroun, le taux de prévalence de la drépanocytose est de 8,34 % dans la population générale.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

25.4 %Hypertension prevalence among rural dwellers in Cameroon was 25.4% [95% CI 17.1–33.7].

Camerounhypertension artériellepublished 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165

73.7 %Among patients with type 1 diabetes, screening for kidney disease was 73.7% in wave 2, 84.1% in wave 3, and 83.4% in wave 7.

Cameroundiabète de type 1 · kidney diseasepublished 2021Diabetologiaeurope_pmcdocument of 14 observations

6 %Depending on tests or algorithms used, up to 6% of HIV-1 M infected patients in Cameroon do not receive ART.

CamerounHIV-1 Mpublished 2009PloS oneeurope_pmcdocument of 6 observations

53,005 inhabitantsA total of 53,005 people was registered in the 190 communities surveyed with 794 (1.4%) individuals identified as suspected cases of epilepsy by the community drug distributors.

CamerounépilepsieHAL · Unilimdocument of 53 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.